巴基斯坦基于网络的药房应用程序的可靠性基于移动应用程序评级表:内容分析和质量评估
Anum Sattar1,2, Hina Rehman3, Safila Naveed4
1Department of Pharmacy Practice, Jinnah University for Women, 5C, Block 5 Nazimabad, Karachi, 74600, Pakistan, 92 3443786840.
JMIR mHealth and uHealth
|April 17, 2025
概括
这项研究使用移动应用评级表 (MARS) 评估了巴基斯坦的在线药房应用程序. 结果显示应用的质量各不相同,用户参与与更好的功能和信息有关,突出显示数字卫生服务需要改进的领域.
科学领域:
- 数字健康数字健康
- 医疗信息学 医疗信息学
- 移动健康 (mHealth) 服务提供商
背景情况:
- 基于Web的药房应用程序对于电子医疗供应交换至关重要.
- 巴基斯坦的数字增长推动了在线药房行业的发展,引发了对应用程序合法性和准确性的担忧.
研究的目的:
- 综合评估巴基斯坦可用的数字药房应用程序.
- 专注于使用移动应用评分表 (MARS) 的谷歌Play商店和iOS应用商店的应用程序.
主要方法:
- 从巴基斯坦的Google Play商店和iOS应用商店分析了23个选定的在线药房应用程序.
- 使用移动应用评级表 (MARS) 进行两位研究人员的独立评估.
- 根据包括语言和下载可用性在内的标准,排除了应用程序.
主要成果:
- 23个评估的应用程序的平均评分在2.64到4.00之间 (升至5级).
- 美学获得了最高的平均得分 (3.6),而信息质量得分最低 (3.2).
- 在用户参与度和应用程序功能/信息质量之间发现了积极的相关性.
结论:
- 这项研究提供了使用MARS的巴基斯坦在线药房应用程序的首次评估.
- 研究结果为这些数字健康平台的可靠性和有效性提供了见解.
- 确定了需要加强的特定维度 (例如信息质量),以获得更好的用户体验和信任.
相关概念视频
Pharmacovigilance
739
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
739
Drug Classes and Categories
1.8K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.8K
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Cellular Membranes and Drug Transport
232
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
232
Drug Distribution: Overview
104
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
104
Structure-Activity Relationships and Drug Design
437
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
437


